Pharmaxis Ltd Corporate Presentation Transcript
Good morning, everyone. The clock has now ticked past 11:00 AM. So we are going to get started with today's very special investor briefing with Pharmaxis CEO, Gary Phillips, who has some exciting clinical data just analyzed from the Phase 2 clinical trials to treat myelofibrosis.
My name is Alferd, and I am part of the Pharmaxis Investor Relations team, and I'm to assist with Gary to run the session.
Just quick formality, after the presentation, Gary will take questions from those in attendance and a few that have been mailed through already. (Conference Instructions) With the data just finalized and released about an hour ago, it's been very busy few days for Pharmaxis. And I'm sure Gary is very excited to present this data. So Gary, I won't take over anymore of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
